Popular on Amzeal
- ProStrategix Proud To Announce Being Chosen as a Top Web Design Agency by DesignRush
- Romance Scams. Senior Women Hit the Hardest - Be Smarter Than Your Phone Cyber Security Podcast
- Black Owned Sneaker Company TRONUS Shakes Up Footwear Industry With Explosive Launch Despite Pandemic
- Trissential Adds New Talent to Leadership Team
- Mr. Brian Peterson assisted A&D Professional Pest Elimination with a GSA Multiple Award Schedule
- Zuora CEO Headlines Keynote Speakers at Optimal: The AI Conference for Procurement Teams
- Syxsense Announces a Customizable Dashboard Designer to Easily Deliver Useful Information to IT and Security Teams in Real-Time
- Minority Tech Entrepreneur Applauds Tech Giants' Million-Dollar Donations, Questions Effectiveness
- HLN Releases Open Source Vaccine Provider Agreement System
- Business Owners Can Find System Flaws Before Cyber Criminals Do with the No-Cost Discovery Assessment from Infoaxis
Similar on Amzeal
- Pastor Tracy S. Williams Talks Sex and Relationships in Her Debut Book: THE GARDEN EXPERIENCE AN ABSTINENCE HANDBOOK FOR GIRLS
- Sugaring: The Green Juice of Hair Removal
- Ideanomics Announces Its Membership in CALSTART
- Syxsense Announces Integration with Microsoft Office 365
- Launch of Trace One E-Sourcing Will Boost Retailers' Private Label Speed to Market
- New Video Streaming Startup, Relax Scenes, Launches Indiegogo Campaign to Support Their Expansion
- Fennemore Names New Office Managing Partners, Practice Group Leaders & Chief Diversity Officer
- Wohler adds to their iVAM range with the launch of the iVAM2-2
- Optimal Empowers Procurement Teams with Expert Best Practices
- BEYOND GUANTANAMO: Louisiana Candidate for Congress blazes trail to freedom for U.S. political prisoners
Braeden Lichti: Healthcare Investing in 2021
Amzeal News/10401963
VANCOUVER, British Columbia - Amzeal -- Tech and healthcare are working together in the COVID-19 pandemic to benefit the greater good. That's why CNBC has predicted that both industries, including biopharma and biotech, will make gains in 2021. COVID-19 has put biopharma in the limelight and big-name tech investors are moving in: for example, tech entrepreneur and Facebook co-founder Peter Thiel recently joined a $35.4 million Series B round for Peptilogics.
Biopharma has made strides in 2020 and is on track for even more milestones in 2021. Big data and machine learning have helped biopharma better understand biological systems and diseases, and have enabled drug discovery, and pre-clinical testing. Such high-tech tools have helped accelerate the pace of innovation by being able to perform high-throughput virtual testing of large databases of molecules to find treatments.
More on Amzeal News
During the COVID-19 pandemic, biopharma has persevered and collaborated at record speed to adapt and incorporate new technologies that can expedite innovation to find treatments and vaccines for the novel coronavirus. The industry has relied heavily on artificial intelligence (AI) and big data to help with the real-time development of vaccines. For example, the Moderna COVID-19 vaccine took 42 days to develop, from mRNA sequence selection to clinical testing, due to the use of computer modeling to help determine what part of the novel coronavirus's spike protein would be best equipped to be used in the vaccine. Similarly, Eli Lilly used AbCellera's AI-driven therapeutic antibody drug discovery platform to identify relevant antibodies needed for the treatment in a period of just three months.
In 2020, software technology helped reduce the high amount of risk inherent in the pharma industry. By using AI for mRNA sequence selection, Moderna saved itself the trouble of years of pre-clinical research, as can be standard in drug development and discovery. What's more, by using computer modelling to identify compounds for therapeutics, this has saved time and failures later on down the line that could occur after a decade or more of clinical trials testing.
More on Amzeal News
Now that we have proven a way to reduce the risk of clinical failures and could potentially speed up drug development in multiple areas of unmet need, the biopharma sector is becoming a more attractive asset class. Machines can help us find drugs that would be normally researched by scientists in labs for years, perhaps even decades, with a high risk of failure once the drug of interest got to clinical trials. Other drugs being worked on in non-COVID-19-related therapeutics use machine learning that helps pick compounds as well. Now that Moderna has found success with the mRNA-1273 vaccine for COVID-19, they are launching new vaccines, including an HIV mRNA vaccine.
Biopharma, despite the inherent risk, is also seen as recession-proof — "the demand for life-saving medications is not going to change," regardless of the time, as Patti Seymour of BDO states. Furthermore, even in economically tough times, healthcare expenditure has stayed the same or increased. Currently, we are at all-time market highs and can expect a pullback or dip. Healthcare innovation is a necessity, though, especially in a pandemic — biopharma is a place to invest for the long term.
Healthcare presents an attractive opportunity, with biotech, medical devices, and medical services, to shine. With significant opportunities to capture above-market gains and beat the market, healthcare may prove a lucrative investment this year.
Biopharma has made strides in 2020 and is on track for even more milestones in 2021. Big data and machine learning have helped biopharma better understand biological systems and diseases, and have enabled drug discovery, and pre-clinical testing. Such high-tech tools have helped accelerate the pace of innovation by being able to perform high-throughput virtual testing of large databases of molecules to find treatments.
More on Amzeal News
- Sandline Global Fortifies World-Class Executive Team: Glenn Hopper Joins as Chief Financial Officer
- RSTOR Enhances Software Defined Cloud Platform to Support Hybrid, Multi-Cloud Enterprise Infrastructures
- GBKSOFT reveals the benefits of Building Websites with PHP in 2021?
- Syxsense Announces Integration with Microsoft Office 365
- Launch of Trace One E-Sourcing Will Boost Retailers' Private Label Speed to Market
During the COVID-19 pandemic, biopharma has persevered and collaborated at record speed to adapt and incorporate new technologies that can expedite innovation to find treatments and vaccines for the novel coronavirus. The industry has relied heavily on artificial intelligence (AI) and big data to help with the real-time development of vaccines. For example, the Moderna COVID-19 vaccine took 42 days to develop, from mRNA sequence selection to clinical testing, due to the use of computer modeling to help determine what part of the novel coronavirus's spike protein would be best equipped to be used in the vaccine. Similarly, Eli Lilly used AbCellera's AI-driven therapeutic antibody drug discovery platform to identify relevant antibodies needed for the treatment in a period of just three months.
In 2020, software technology helped reduce the high amount of risk inherent in the pharma industry. By using AI for mRNA sequence selection, Moderna saved itself the trouble of years of pre-clinical research, as can be standard in drug development and discovery. What's more, by using computer modelling to identify compounds for therapeutics, this has saved time and failures later on down the line that could occur after a decade or more of clinical trials testing.
More on Amzeal News
- Australian Content Farm Kantado gets its first US hit single
- New Video Streaming Startup, Relax Scenes, Launches Indiegogo Campaign to Support Their Expansion
- Bronx DWI Lawyer Announces New Website
- Recording Artist "Cherne" Crystal Brown auditions for Sony Music, Atlantic Records and Capitol Records and it doesn't stop there
- Technicolor HERO Partners Weigh in on Network Service Provider Trends Established in 2020 and Offer Views on What to Expect in 2021
Now that we have proven a way to reduce the risk of clinical failures and could potentially speed up drug development in multiple areas of unmet need, the biopharma sector is becoming a more attractive asset class. Machines can help us find drugs that would be normally researched by scientists in labs for years, perhaps even decades, with a high risk of failure once the drug of interest got to clinical trials. Other drugs being worked on in non-COVID-19-related therapeutics use machine learning that helps pick compounds as well. Now that Moderna has found success with the mRNA-1273 vaccine for COVID-19, they are launching new vaccines, including an HIV mRNA vaccine.
Biopharma, despite the inherent risk, is also seen as recession-proof — "the demand for life-saving medications is not going to change," regardless of the time, as Patti Seymour of BDO states. Furthermore, even in economically tough times, healthcare expenditure has stayed the same or increased. Currently, we are at all-time market highs and can expect a pullback or dip. Healthcare innovation is a necessity, though, especially in a pandemic — biopharma is a place to invest for the long term.
Healthcare presents an attractive opportunity, with biotech, medical devices, and medical services, to shine. With significant opportunities to capture above-market gains and beat the market, healthcare may prove a lucrative investment this year.
Source: Braeden Lichti
0 Comments
Latest on Amzeal News
- Infogix Recognized for Data Catalog Solution by Industry Leading Media and Analysts
- Fennemore Names New Office Managing Partners, Practice Group Leaders & Chief Diversity Officer
- Apex Process Consultants announces No Code forms
- HyAlto certifies with Datto Autotask PSA
- Wohler adds to their iVAM range with the launch of the iVAM2-2
- Optimal Empowers Procurement Teams with Expert Best Practices
- BEYOND GUANTANAMO: Louisiana Candidate for Congress blazes trail to freedom for U.S. political prisoners
- 8th Annual American Reality TV Awards - ARTAS Official Nominations
- Thirst for Japanese Whisky Strong as New Standards Set
- PEVO Sports Co. was recently awarded two GSA contracts with Brian Peterson and the Government Marketplace LLC team's assistance
- eCollections Debt Management Platform Announces New Business Import Tool
- International HPV Awareness Day Summit
- Legacy Gospel Series Project - New Previously Unreleased Recordings
- Winter Storm Damage and Your Insurance Claim
- Most Effective Tools for Promoting Your Event on Facebook by Entrepreneur Ismail Sirdah
- Mentorship Book Featuring Successful Black Lawyers Created for Black Law School Aspirants Available Now for Free
- NEAT Expands Application to Olfactory and Degustation Sensory Diagnostics
- California Pools Opens Atlanta Location, Expanding Its Industry Leadership
- Avionics Veteran Preston Dane joins L2 Aviation as Senior Account Manager
- Durante Rentals Hires Industry Veteran Steve Durante as Chief Sales Officer